Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/52204
Title: Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis
Author: Rubio Valera, Maria
Serrano Blanco, Antoni
Magdalena Belío, Jesús
Fernández Sánchez, Ana
García Campayo, Javier
March Pujol, Marian
López del Hoyo, Yolanda
Keywords: Depressió psíquica
Serveis farmacèutics
Cooperació dels malalts
Antidepressius
Atenció primària
Metaanàlisi
Mental depression
Pharmaceutical services
Patient compliance
Antidepressants
Primary health care
Meta-analysis
Issue Date: 1-Jan-2011
Publisher: Sage Publications
Abstract: BACKGROUND: Pharmacists can play a decisive role in the management of ambulatory patients with depression who have poor adherence to antidepressant drugs. OBJECTIVE: To systematically evaluate the effectiveness of pharmacist care in improving adherence of depressed outpatients to antidepressants. METHODS: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted. RCTs were identified through electronic databases (MEDLINE, Cochrane Central Register of Controlled Trials, Institute for Scientific Information Web of Knowledge, and Spanish National Research Council) from inception to April 2010, reference lists were checked, and experts were consulted. RCTs that evaluated the impact of pharmacist interventions on improving adherence to antidepressants in depressed patients in an outpatient setting (community pharmacy or pharmacy service) were included. Methodologic quality was assessed and methodologic details and outcomes were extracted in duplicate. RESULTS: Six RCTs were identified. A total of 887 patients with an established diagnosis of depression who were initiating or maintaining pharmacologic treatment with antidepressant drugs and who received pharmacist care (459 patients) or usual care (428 patients) were included in the review. The most commonly reported interventions were patient education and monitoring, monitoring and management of toxicity and adverse effects, adherence promotion, provision of written or visual information, and recommendation or implementation of changes or adjustments in medication. Overall, no statistical heterogeneity or publication bias was detected. The pooled odds ratio, using a random effects model, was 1.64 (95% CI 1.24 to 2.17). Subgroup analysis showed no statistically significant differences in results by type of pharmacist involved, adherence measure, diagnostic tool, or analysis strategy. CONCLUSIONS: These results suggest that pharmacist intervention is effective in the improvement of patient adherence to antidepressants. However, data are still limited and we would recommend more research in this area, specifically outside of the US.
Note: Versió postprint del document publicat a: http://dx.doi.org/10.1345/aph.1P429
It is part of: Annals of Pharmacotherapy, 2011, vol. 45, num. 1, p. 39-48
Related resource: http://dx.doi.org/10.1345/aph.1P429
URI: http://hdl.handle.net/2445/52204
ISSN: 1060-0280
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
590019.pdf220.58 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.